Shom Goel
14PUBLICATIONS
127CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Feb 26, 2025
Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer.Ana C Garrido-Castro, Noah Graham, Lestat R Ali
|Feb 05, 2025
A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer.Shom Goel, Bojana Jovanović, Xiangying Chu
|Aug 13, 2024
Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies.Bojana Jovanović, Sarah E Church, Kara M Gorman
|Jul 29, 2024
The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer.Kamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler
|Dec 04, 2023
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors.Catherine Dietrich, Alec Trub, Antonio Ahn
Pageof 3
Frequent Collaborators
6 joint publications
Sara M Tolaney
3 joint publications
Lestat R Ali
2 joint publications
Nancy U Lin
2 joint publications
Henry W Long
2 joint publications
Melissa Hughes
2 joint publications
Molly DiLullo
2 joint publications
April C Watt
2 joint publications
Bojana Jovanović
2 joint publications
Geoffrey I Shapiro
2 joint publications
Jean J Zhao